Fabio Rinaldi

Last updated

Dr. Fabio Rinaldi is head of NLP research at IDSIA, Switzerland. He earned his PhD in Computational Linguistics from the University of Zurich, Switzerland in 2008. He continued to work at the University of Zurich as a lecturer, senior researcher and group leader until 2020.

Contents

Currently, Rinaldi is a group leader at the Swiss Institute of Bioinformatics (SIB), [1] and a visiting scientist at the Center for Genomic Sciences [2] (UNAM, Mexico), where he collaborates with the RegulonDB group.

He is the initiator and team leader of the OntoGene research group, [3] which focuses on Text Mining for biomedical applications.

Rinaldi is a very active contributor to the field of biomedical text mining. [4] [5] He is one of the co-organizers of the well-known BioCreAtIvE [6] challenges on evaluation of biomedical text mining technologies.

Selected publications

  1. Rinaldi, F. (2008). "Laser: A review". Clinics in Dermatology. 26 (6): 590–601. doi:10.1016/j.clindermatol.2007.09.014. PMID   18940539. S2CID   19718531.
  2. Rinaldi, F.; Clematide, S.; Garten, Y.; Whirl-Carrillo, M.; Gong, L.; Hebert, J. M.; Sangkuhl, K.; Thorn, C. F.; Klein, T. E.; Altman, R. B. (2012). "Using ODIN for a PharmGKB revalidation experiment". Database. 2012: bas021. doi:10.1093/database/bas021. PMC   3332569 . PMID   22529178.
  3. Rinaldi, F.; Schneider, G.; Clematide, S. (2012). "Relation mining experiments in the pharmacogenomics domain". Journal of Biomedical Informatics. 45 (5): 851–861. doi: 10.1016/j.jbi.2012.04.014 . PMID   22580177.
  4. Rinaldi, F.; Clematide, S.; Hafner, S.; Schneider, G.; Grigonyte, G.; Romacker, M.; Vachon, T. (2013). "Using the OntoGene pipeline for the triage task of BioCreative 2012". Database. 2013: bas053. doi:10.1093/database/bas053. PMC   3568389 . PMID   23396322.
  5. Rinaldi, F.; Najafi, B. (2013). "Temperature measurement in WTE boilers using suction pyrometers". Sensors. 13 (11): 15633–15655. Bibcode:2013Senso..1315633R. doi: 10.3390/s131115633 . PMC   3871099 . PMID   24248279.
  6. Rinaldi, F.; Ellendorff, T. R.; Madan, S.; Clematide, S.; Van Der Lek, A.; Mevissen, T.; Fluck, J. (2016). "BioCreative V track 4: A shared task for the extraction of causal network information using the Biological Expression Language". Database. 2016: baw067. doi:10.1093/database/baw067. PMC   4940434 . PMID   27402677.
  7. Sorbellini, E.; Pinto, D.; Marzani, B.; Rinaldi, F. (2018). "Drug Treatment for Androgenetic Alopecia: First Italian Questionnaire Survey on What Dermatologists Think about Finasteride". Dermatology and Therapy. 8 (2): 259–267. doi:10.1007/s13555-018-0233-6. PMC   6002321 . PMID   29574572.
  8. Marzani, B.; Pinto, D.; Sorbellini, E.; Rinaldi, F. (2018). "New multi-targeting strategy in hair growth promotion: In vitro and in vivo studies". Giornale Italiano di Dermatologia e Venereologia. 153 (3): 338–343. PMID   29766701.
  9. De Padova, M. P.; Marzani, B.; Pinto, D.; Rinaldi, F. (2018). "A Single-Arm, Open-Label, Phase IV Study to Evaluate the Efficacy of a Topical Formulation for Hyperkeratotic Actinic Keratosis Lesions". Dermatology and Therapy. 8 (3): 455–462. doi:10.1007/s13555-018-0252-3. PMC   6109024 . PMID   30054800.
  10. Furrer, L.; Jancso, A.; Colic, N.; Rinaldi, F. (2019). "OGER++: Hybrid multi-type entity recognition". Journal of Cheminformatics. 11 (1): 7. doi: 10.1186/s13321-018-0326-3 . PMC   6689863 . PMID   30666476.
  11. Rinaldi, F.; Trink, A.; Pinto, D. (2020). "Efficacy of Postbiotics in a PRP-Like Cosmetic Product for the Treatment of Alopecia Area Celsi: A Randomized Double-Blinded Parallel-Group Study". Dermatology and Therapy. 10 (3): 483–493. doi:10.1007/s13555-020-00369-9. PMC   7211773 . PMID   32279227.
  12. Rinaldi, F.; Trink, A.; Giuliani, G.; Pinto, D. (2021). "Italian Survey for the Evaluation of the Effects of Coronavirus Disease 2019 (COVID-19) Pandemic on Alopecia Areata Recurrence". Dermatology and Therapy. 11 (2): 339–345. doi:10.1007/s13555-021-00498-9. PMC   7880634 . PMID   33580408.
  13. Davoodijam, E.; Ghadiri, N.; Lotfi Shahreza, M.; Rinaldi, F. (2021). "MultiGBS: A multi-layer graph approach to biomedical summarization". Journal of Biomedical Informatics. 116. arXiv: 2008.11908 . doi: 10.1016/j.jbi.2021.103706 . PMID   33610879. S2CID   221340611.
  14. Babino, G.; Caccavale, S.; Pinto, D.; Trink, A.; Giuliani, G.; Rinaldi, F.; Argenziano, G. (2021). "A Randomized Double-Blind Parallel-Group Study to Evaluate the Long-Term Effects of a Medical Device Containing 0.3% Octatrienoic Acid in the Treatment of Grade III Actinic Keratosis". Dermatology and Therapy. 11 (5): 1751–1762. doi:10.1007/s13555-021-00594-w. PMC   8484398 . PMID   34476756.
  15. Kanjirangat, V.; Rinaldi, F. (2021). "Enhancing Biomedical Relation Extraction with Transformer Models using Shortest Dependency Path Features and Triplet Information". Journal of Biomedical Informatics. 122. doi: 10.1016/j.jbi.2021.103893 . PMID   34481058. S2CID   237417517.
  16. Zanoli, R.; Lavelli, A.; Löffler, T.; Perez Gonzalez, N. A.; Rinaldi, F. (2022). "An annotated dataset for extracting gene-melanoma relations from scientific literature". Journal of Biomedical Semantics. 13 (1): 2. doi: 10.1186/s13326-021-00251-3 . PMC   8772125 . PMID   35045882.
  17. Rinaldi, F.; Marotta, L.; Mascolo, A.; Amoruso, A.; Pane, M.; Giuliani, G.; Pinto, D. (2022). "Facial Acne: A Randomized, Double-Blind, Placebo-Controlled Study on the Clinical Efficacy of a Symbiotic Dietary Supplement". Dermatology and Therapy. 12 (2): 577–589. doi:10.1007/s13555-021-00664-z. PMC   8850513 . PMID   35061237.
  18. Furrer, L.; Cornelius, J.; Rinaldi, F. (2022). "Parallel sequence tagging for concept recognition". BMC Bioinformatics. 22 (Suppl 1): 623. doi: 10.1186/s12859-021-04511-y . PMC   8943923 . PMID   35331131.
  19. Shaitarova, A.; Zaghir, J.; Lavelli, A.; Krauthammer, M.; Rinaldi, F. (2023). "Exploring the Latest Highlights in Medical Natural Language Processing across Multiple Languages: A Survey". Yearbook of Medical Informatics. 32 (1): 230-243. doi: 10.1055/s-0043-1768726 . PMC   10751112 . PMID   38147865.

Notes


Related Research Articles

<span class="mw-page-title-main">Psoriasis</span> Skin disease

Psoriasis is a long-lasting, noncontagious autoimmune disease characterized by patches of abnormal skin. These areas are red, pink, or purple, dry, itchy, and scaly. Psoriasis varies in severity from small localized patches to complete body coverage. Injury to the skin can trigger psoriatic skin changes at that spot, which is known as the Koebner phenomenon.

<span class="mw-page-title-main">Basal-cell carcinoma</span> Most common type of skin cancer

Basal-cell carcinoma (BCC), also known as basal-cell cancer, basalioma or rodent ulcer, is the most common type of skin cancer. It often appears as a painless raised area of skin, which may be shiny with small blood vessels running over it. It may also present as a raised area with ulceration. Basal-cell cancer grows slowly and can damage the tissue around it, but it is unlikely to spread to distant areas or result in death.

<span class="mw-page-title-main">Adapalene</span> Third-generation topical retinoid

Adapalene is a third-generation topical retinoid primarily used in the treatment of mild-moderate acne, and is also used off-label to treat keratosis pilaris as well as other skin conditions. Studies have found adapalene is as effective as other retinoids, while causing less irritation. It also has several advantages over other retinoids. The adapalene molecule is more stable compared to tretinoin and tazarotene, which leads to less concern for photodegradation. It is also chemically more stable compared to the other two retinoids, allowing it to be used in combination with benzoyl peroxide. Due to its effects on keratinocyte proliferation and differentiation, adapalene is superior to tretinoin for the treatment of comedonal acne and is often used as a first-line agent. The Swiss company Galderma sells adapalene under the brand-name product Differin.

<span class="mw-page-title-main">Telogen effluvium</span> Medical condition

Telogen effluvium is a scalp disorder characterized by the thinning or shedding of hair resulting from the early entry of hair in the telogen phase. It is in this phase that telogen hairs begin to shed at an increased rate, where normally the approximate rate of hair loss is 125 hairs per day.

<span class="mw-page-title-main">Alopecia universalis</span> Medical condition

Alopecia universalis(AU), also known as alopecia areata universalis, is a medical condition involving the loss of all body hair, including eyebrows, eyelashes, chest hair, armpit hair, and pubic hair. It is the most severe form of alopecia areata. People with the disease are usually healthy and have no other symptoms and a normal life expectancy.

<span class="mw-page-title-main">Seborrheic keratosis</span> Skin disease

A seborrheic keratosis is a non-cancerous (benign) skin tumour that originates from cells, namely keratinocytes, in the outer layer of the skin called the epidermis. Like liver spots, seborrheic keratoses are seen more often as people age.

Traction alopecia is a type of alopecia or hair loss caused by a chronic pulling force being applied to the hair. It commonly results from a person frequently wearing their hair in a particularly tight ponytail, pigtails, or braids with increased likelihood when hair is chemically relaxed as this compromises the hair shaft's tensile strength resulting in hair breakage. Traction alopecia causes a recession of the hairline due to chronic traction, which is characterized by a fringe along the marginal hairline on physical exam. Diagnosis is clinical and treatment directed at cessation of the chronic traction, while cosmeses, with surgical restoration is reserved for severe cases with scarring fibrosis.

The management of hair loss, includes prevention and treatment of alopecia, baldness, and hair thinning, and regrowth of hair.

<span class="mw-page-title-main">Alopecia totalis</span> Medical condition

Alopecia totalis is the loss of all hair on the head and face. Its causes are unclear, but believed to be autoimmune. Research suggests there may be a genetic component linked to developing alopecia totalis; the presence of DRB1*0401 and DQB1*0301, both of which are human leukocyte antigens (HLA), were found to be associated with long-standing alopecia totalis.

Biomedical text mining refers to the methods and study of how text mining may be applied to texts and literature of the biomedical domain. As a field of research, biomedical text mining incorporates ideas from natural language processing, bioinformatics, medical informatics and computational linguistics. The strategies in this field have been applied to the biomedical literature available through services such as PubMed.

<span class="mw-page-title-main">Pattern hair loss</span> Medical condition

Pattern hair loss is a hair loss condition that primarily affects the top and front of the scalp. In male-pattern hair loss (MPHL), the hair loss typically presents itself as either a receding front hairline, loss of hair on the crown (vertex) of the scalp, or a combination of both. Female-pattern hair loss (FPHL) typically presents as a diffuse thinning of the hair across the entire scalp.

<span class="mw-page-title-main">Actinic cheilitis</span> Medical condition

Actinic cheilitis is cheilitis caused by long term sunlight exposure. Essentially it is a burn, and a variant of actinic keratosis which occurs on the lip. It is a premalignant condition, as it can develop into squamous cell carcinoma.

<span class="mw-page-title-main">Nadifloxacin</span> Chemical compound

Nadifloxacin is a topical fluoroquinolone antibiotic for the treatment of acne vulgaris. It is also used to treat bacterial skin infections.

<span class="mw-page-title-main">Low-level laser therapy</span> Treatment using irradiation with light of low power intensity

Low-level laser therapy (LLLT), cold laser therapy, photobiomodulation (PBM) or red light therapy is a form of medicine that applies low-level (low-power) lasers or light-emitting diodes (LEDs) to the surface of the body. Whereas high-power lasers are used in laser medicine to cut or destroy tissue, it is claimed that application of low-power lasers relieves pain or stimulates and enhances cell function. The effects appear to be limited to a specified set of wavelengths and new research has demonstrated effectiveness at myopia control. Several such devices are cleared by the United States Food and Drug Administration (FDA), and research shows potential for treating a range of medical problems including rheumatoid arthritis and oral mucositis.

Keratosis follicularis spinulosa decalvans is a rare X-linked disorder described by Siemens in 1926. It is a disease that begins in infancy with keratosis pilaris localized on the face, then evolves to more diffuse involvement.

<span class="mw-page-title-main">Platelet-rich plasma</span> Blood product used in transfusion medicine

Platelet-rich plasma (PRP), also known as autologous conditioned plasma, is a concentrate of platelet-rich plasma protein derived from whole blood, centrifuged to remove red blood cells. Though promoted to treat an array of medical problems, evidence for benefit is mixed as of 2020, with some evidence for use in certain conditions and against use in other conditions.

The growth of human hair occurs everywhere on the body except for the soles of the feet, the palms of the hands, the inside of the mouth, the lips, the backs of the ears, some external genital areas, the navel, scar tissue, and, apart from eyelashes, the eyelids. Hair is a stratified squamous keratinized epithelium made of multi-layered flat cells whose rope-like filaments provide structure and strength to the hair shaft. The protein called keratin makes up hair and stimulates hair growth. Hair follows a specific growth cycle with three distinct and concurrent phases: anagen, catagen, and telogen. Each phase has specific characteristics that determine the length of the hair.

<span class="mw-page-title-main">Literature-based discovery</span> Research method using published knowledge as data

Literature-based discovery (LBD), also called literature-related discovery (LRD) is a form of knowledge extraction and automated hypothesis generation that uses papers and other academic publications to find new relationships between existing knowledge. Literature-based discovery aims to discover new knowledge by connecting information which have been explicitly stated in literature to deduce connections which have not been explicitly stated.

In molecular biology mir-153 microRNA is a short RNA molecule. MicroRNAs function to regulate the expression levels of other genes by several mechanisms.

Laser-assisted drug delivery (LADD) is a drug delivery technique commonly used in the dermatology field that involves lasers. As skin acts as a protective barrier to the environment, the absorption of topical products through the epidermis is limited; thus, different drug delivery modalities have been employed to improve the efficacy of these treatments. The use of lasers in LADD has been shown to enhance the penetration of drugs transdermal, leading to a higher absorption rate, limited systemic effects, and reduced duration of treatment. Although this technique has evolved in the past decade due to its efficacy through scientific research and clinical practice, there remain some limitations regarding the safety aspect that needs to be taken into consideration.